A greater understanding of molecular and cellular biology and technological advancements are revolutionizing the field of ...

The company is presenting preclinical data at the American Society of Gene & Cell Therapy annual meeting that supports the potential of the company’s CAP-002 gene therapy for correcting neurological ...

Experiments conducted by the downstream technology team at Spark Therapeutics involving metal ion-containing additives showed improved capsid clearance in AAV production. Certain additives or a ...

The request for more information was received weeks after an application to the FTC was refiled to approve the deal. The United States Federal Trade Commission (FTC) is seeking more information on ...

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, ...

The report covers the major achievements of the office during 2023, including notable drug approvals, publications, guidances, workshops, webinars, and meetings.

Meeta B. Kratz (Global Vice President, Product Management & Marketing, Lonza Capsule and Health Ingredients) talks about ...

Explore how Rentschler Biopharma duels biopharmaceutical innovation, spanning from pioneering biological products to ...

Santander UK, a retail and commercial bank based in the United Kingdom, has announced it has provided Ennogen Healthcare International, a UK-based pharmaceuticals manufacturer, with a £30 million loan ...

Bill Humphries (CEO, Alcami) dives into an overview of Alcami's capabilities and how they value their client's innovations.

The collaboration will combine N4’s nanoparticle delivery system with SRI’s molecular guidance system. N4 Pharma, a pre-clinical stage specialist pharmaceutical company, has formed a research ...

The agreement, which will allow participants to share confidential information on medical and medicinal products, builds on the cooperation fostered between the two regulatory authorities during the ...